Characterization of stem-like cells in a new astroblastoma cell line

被引:6
作者
Coban, Esra Aydemir [1 ]
Kasikci, Ezgi [1 ]
Karatas, Omer Faruk [2 ]
Suakar, Oznur [3 ,4 ]
Kuskucu, Aysegul [3 ,4 ]
Altunbek, Mine
Ture, Ugur [5 ]
Sahin, Fikrettin [1 ]
Bayrak, Omer Faruk [3 ,4 ]
机构
[1] Yeditepe Univ, Fac Engn & Architecture, Dept Genet & Bioengn, Istanbul, Turkey
[2] Erzurum Tech Univ, Mol Biol & Genet Dept, Erzurum, Turkey
[3] Yeditepe Univ, Sch Med, Dept Med Genet, Istanbul, Turkey
[4] Yeditepe Univ Hosp, Istanbul, Turkey
[5] Yeditepe Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey
关键词
Astroblastoma; Cancer; Cancer stem cell; OPTIC PATHWAY GLIOMA; IN-VITRO; IDENTIFICATION; EXPRESSION; ADULT; DIFFERENTIATION; MEDULLOBLASTOMA; ARREST; TUMORS;
D O I
10.1016/j.yexcr.2017.02.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell lines established from tumors are the most commonly used models in cancer research, and their use in recent years has enabled a greater understanding of the biology of cancer and the means to develop effective treatment strategies. Astroblastomas are uncommon neuroepithelial tumors of glial origin, predominantly affecting young people, mainly teenagers and children, predominantly females. To date, only a single study has reported that astroblastomas contain a large number of neural stem-like cells, which had only a partial proliferation capacity and differentiation. Our objective was to establish an astroblastoma cell line to investigate the presence of astroblastic cells and cancer stem-like cells. The migratory and invasion abilities of the cells were quantified with invasion and migration assays and compared to a glioblastoma cell line. The presence of stem cells was detected with surface-marker analysis by using flow cytometry, and measuring the differentiation ability with a differentiation assay and the self-renewal capacity with a sphere-forming assay. These characteristics may determine whether this novel cell line is a model for astroblastomas that may have stem cell characteristics. With this novel cell line, scientists can investigate the molecular pathways underlying astroblastomas and develop new therapeutic strategies for patients with these tumors.
引用
收藏
页码:393 / 402
页数:10
相关论文
共 42 条
[1]   Astroblastomas: A Surveillance, Epidemiology, and End Results (SEER)-Based Patterns of Care Analysis [J].
Ahmed, Kamran A. ;
Allen, Pamela K. ;
Mahajan, Anita ;
Brown, Paul D. ;
Ghia, Amol J. .
WORLD NEUROSURGERY, 2014, 82 (1-2) :E291-E297
[2]   Cancer stem cells in solid tumors [J].
Ailles, Laurie E. ;
Weissman, Irving L. .
CURRENT OPINION IN BIOTECHNOLOGY, 2007, 18 (05) :460-466
[3]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[4]   5-S-Cysteinyldopamine Neurotoxicity: Influence on the Expression of α-Synuclein and ERp57 in Cellular and Animal Models of Parkinson's Disease [J].
Aureli, Cristina ;
Cassano, Tommaso ;
Masci, Alessandra ;
Francioso, Antonio ;
Martire, Sara ;
Cocciolo, Annalisa ;
Chichiarelli, Silvia ;
Romano, Adele ;
Gaetani, Silvana ;
Mancini, Patrizia ;
Fontana, Mario ;
d'Erme, Maria ;
Mosca, Luciana .
JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (03) :347-358
[5]   Characterization of cancer stem-like cells in chordoma Laboratory investigation [J].
Aydemir, Esra ;
Bayrak, Omer Faruk ;
Sahin, Fikrettin ;
Atalay, Basar ;
Kose, Gamze Torun ;
Ozen, Mustafa ;
Sevli, Serhat ;
Dalan, Altay Burak ;
Yalvac, Mehmet Emir ;
Dogruluk, Turgut ;
Ture, Ugur .
JOURNAL OF NEUROSURGERY, 2012, 116 (04) :810-820
[6]   Role of melatonin on differentiation of mesenchymal stem cells derived from third molar germ tissue [J].
Aydogdu, Nurullah ;
Tasli, Pakize Neslihan ;
Sisli, Hatice Burcu ;
Yalvac, Mehmet Emir ;
Sahin, Fikrettin .
TURKISH JOURNAL OF BIOLOGY, 2016, 40 (02) :430-442
[7]  
Brat DJ, 2000, BRAIN PATHOL, V10, P342
[8]   Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: Minimizing the life years lost attributable to failure to control the disease and late complication risk [J].
Brodin, N. Patrik ;
Vogelius, Ivan R. ;
Bjork-Eriksson, Thomas ;
af Rosenschold, Per Munck ;
Maraldo, Maja V. ;
Aznar, Marianne C. ;
Specht, Lena ;
Bentzen, Soren M. .
ACTA ONCOLOGICA, 2014, 53 (04) :462-470
[9]  
Bruederlein Silke, 2010, Sarcoma, V2010, P630129, DOI 10.1155/2010/630129
[10]  
Cardellicchio S, 2014, NEUROPEDIATRICS, V45, P42, DOI 10.1055/s-0033-1360482